Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

Lars Iversen Gjærde; Leah Shepherd; Elzbieta Jablonowska; Adriano Lazzarin; Mathieu Rougemont; Katharine Darling; Manuel Battegay; Dominique Braun; Valerie Martel-Laferriere; Jens D Lundgren; Jürgen K Rockstroh; John Gill; Andri Rauch; Amanda Mocroft; Marina B Klein; Lars Peters

doi:10.1093/cid/ciw380

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

Lars Iversen Gjærde, Leah Shepherd, Elzbieta Jablonowska, Adriano Lazzarin, Mathieu Rougemont, Katharine Darling, Manuel Battegay, Dominique Braun, Valerie Martel-Laferriere, Jens D Lundgren, Jürgen K Rockstroh, John Gill, Andri Rauch, Amanda Mocroft, Marina B Klein, Lars Peters

Department of Clinical Medicine

27 Citations (Scopus)

Abstract

BACKGROUND: While liver-related deaths in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected individuals have declined over the last decade, hepatocellular carcinoma (HCC) may have increased. We describe the epidemiology of HCC and other liver events in a multicohort collaboration of HIV/HCV-coinfected individuals.

METHODS: We studied HCV antibody-positive adults with HIV in the EuroSIDA study, the Southern Alberta Clinic Cohort, the Canadian Co-infection Cohort, and the Swiss HIV Cohort study from 2001 to 2014. We calculated the incidence of HCC and other liver events (defined as liver-related deaths or decompensations, excluding HCC) and used Poisson regression to estimate incidence rate ratios.

RESULTS: Our study comprised 7229 HIV/HCV-coinfected individuals (68% male, 90% white). During follow-up, 72 cases of HCC and 375 other liver events occurred, yielding incidence rates of 1.6 (95% confidence interval [CI], 1.3, 2.0) and 8.6 (95% CI, 7.8, 9.5) cases per 1000 person-years of follow-up, respectively. The rate of HCC increased 11% per calendar year (95% CI, 4%, 19%) and decreased 4% for other liver events (95% CI, 2%, 7%), but only the latter remained statistically significant after adjustment for potential confounders. Older age, cirrhosis, and low current CD4 cell count were associated with a higher incidence of both HCC and other liver events.

CONCLUSIONS: In HIV/HCV-coinfected individuals, the crude incidence of HCC increased from 2001 to 2014, while other liver events declined. Individuals with cirrhosis or low current CD4 cell count are at highest risk of developing HCC or other liver events.

Original language	English
Journal	Clinical Infectious Diseases
Volume	63
Issue number	6
Pages (from-to)	821-829
Number of pages	9
ISSN	1058-4838
DOIs	https://doi.org/10.1093/cid/ciw380
Publication status	Published - 15 Sept 2016

Keywords

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciw380

ciw380.pdfFinal published version, 389 KB

Cite this

Gjærde, L. I., Shepherd, L., Jablonowska, E., Lazzarin, A., Rougemont, M., Darling, K., Battegay, M., Braun, D., Martel-Laferriere, V., Lundgren, J. D., Rockstroh, J. K., Gill, J., Rauch, A., Mocroft, A., Klein, M. B., & Peters, L. (2016). Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study. Clinical Infectious Diseases, 63(6), 821-829. https://doi.org/10.1093/cid/ciw380

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014 : A Multicohort Study. / Gjærde, Lars Iversen; Shepherd, Leah; Jablonowska, Elzbieta et al.

In: Clinical Infectious Diseases, Vol. 63, No. 6, 15.09.2016, p. 821-829.

Research output: Contribution to journal › Journal article › Research › peer-review

Gjærde, LI, Shepherd, L, Jablonowska, E, Lazzarin, A, Rougemont, M, Darling, K, Battegay, M, Braun, D, Martel-Laferriere, V, Lundgren, JD, Rockstroh, JK, Gill, J, Rauch, A, Mocroft, A, Klein, MB & Peters, L 2016, 'Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study', Clinical Infectious Diseases, vol. 63, no. 6, pp. 821-829. https://doi.org/10.1093/cid/ciw380

@article{dbe8171682cb44e8968ee53cfbf6ac62,

title = "Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study",

abstract = "BACKGROUND: While liver-related deaths in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected individuals have declined over the last decade, hepatocellular carcinoma (HCC) may have increased. We describe the epidemiology of HCC and other liver events in a multicohort collaboration of HIV/HCV-coinfected individuals.METHODS: We studied HCV antibody-positive adults with HIV in the EuroSIDA study, the Southern Alberta Clinic Cohort, the Canadian Co-infection Cohort, and the Swiss HIV Cohort study from 2001 to 2014. We calculated the incidence of HCC and other liver events (defined as liver-related deaths or decompensations, excluding HCC) and used Poisson regression to estimate incidence rate ratios.RESULTS: Our study comprised 7229 HIV/HCV-coinfected individuals (68% male, 90% white). During follow-up, 72 cases of HCC and 375 other liver events occurred, yielding incidence rates of 1.6 (95% confidence interval [CI], 1.3, 2.0) and 8.6 (95% CI, 7.8, 9.5) cases per 1000 person-years of follow-up, respectively. The rate of HCC increased 11% per calendar year (95% CI, 4%, 19%) and decreased 4% for other liver events (95% CI, 2%, 7%), but only the latter remained statistically significant after adjustment for potential confounders. Older age, cirrhosis, and low current CD4 cell count were associated with a higher incidence of both HCC and other liver events.CONCLUSIONS: In HIV/HCV-coinfected individuals, the crude incidence of HCC increased from 2001 to 2014, while other liver events declined. Individuals with cirrhosis or low current CD4 cell count are at highest risk of developing HCC or other liver events.",

keywords = "Journal Article",

author = "Gj{\ae}rde, {Lars Iversen} and Leah Shepherd and Elzbieta Jablonowska and Adriano Lazzarin and Mathieu Rougemont and Katharine Darling and Manuel Battegay and Dominique Braun and Valerie Martel-Laferriere and Lundgren, {Jens D} and Rockstroh, {J{\"u}rgen K} and John Gill and Andri Rauch and Amanda Mocroft and Klein, {Marina B} and Lars Peters",

year = "2016",

month = sep,

day = "15",

doi = "10.1093/cid/ciw380",

language = "English",

volume = "63",

pages = "821--829",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014

T2 - A Multicohort Study

AU - Gjærde, Lars Iversen

AU - Shepherd, Leah

AU - Jablonowska, Elzbieta

AU - Lazzarin, Adriano

AU - Rougemont, Mathieu

AU - Darling, Katharine

AU - Battegay, Manuel

AU - Braun, Dominique

AU - Martel-Laferriere, Valerie

AU - Lundgren, Jens D

AU - Rockstroh, Jürgen K

AU - Gill, John

AU - Rauch, Andri

AU - Mocroft, Amanda

AU - Klein, Marina B

AU - Peters, Lars

PY - 2016/9/15

Y1 - 2016/9/15

N2 - BACKGROUND: While liver-related deaths in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected individuals have declined over the last decade, hepatocellular carcinoma (HCC) may have increased. We describe the epidemiology of HCC and other liver events in a multicohort collaboration of HIV/HCV-coinfected individuals.METHODS: We studied HCV antibody-positive adults with HIV in the EuroSIDA study, the Southern Alberta Clinic Cohort, the Canadian Co-infection Cohort, and the Swiss HIV Cohort study from 2001 to 2014. We calculated the incidence of HCC and other liver events (defined as liver-related deaths or decompensations, excluding HCC) and used Poisson regression to estimate incidence rate ratios.RESULTS: Our study comprised 7229 HIV/HCV-coinfected individuals (68% male, 90% white). During follow-up, 72 cases of HCC and 375 other liver events occurred, yielding incidence rates of 1.6 (95% confidence interval [CI], 1.3, 2.0) and 8.6 (95% CI, 7.8, 9.5) cases per 1000 person-years of follow-up, respectively. The rate of HCC increased 11% per calendar year (95% CI, 4%, 19%) and decreased 4% for other liver events (95% CI, 2%, 7%), but only the latter remained statistically significant after adjustment for potential confounders. Older age, cirrhosis, and low current CD4 cell count were associated with a higher incidence of both HCC and other liver events.CONCLUSIONS: In HIV/HCV-coinfected individuals, the crude incidence of HCC increased from 2001 to 2014, while other liver events declined. Individuals with cirrhosis or low current CD4 cell count are at highest risk of developing HCC or other liver events.

AB - BACKGROUND: While liver-related deaths in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected individuals have declined over the last decade, hepatocellular carcinoma (HCC) may have increased. We describe the epidemiology of HCC and other liver events in a multicohort collaboration of HIV/HCV-coinfected individuals.METHODS: We studied HCV antibody-positive adults with HIV in the EuroSIDA study, the Southern Alberta Clinic Cohort, the Canadian Co-infection Cohort, and the Swiss HIV Cohort study from 2001 to 2014. We calculated the incidence of HCC and other liver events (defined as liver-related deaths or decompensations, excluding HCC) and used Poisson regression to estimate incidence rate ratios.RESULTS: Our study comprised 7229 HIV/HCV-coinfected individuals (68% male, 90% white). During follow-up, 72 cases of HCC and 375 other liver events occurred, yielding incidence rates of 1.6 (95% confidence interval [CI], 1.3, 2.0) and 8.6 (95% CI, 7.8, 9.5) cases per 1000 person-years of follow-up, respectively. The rate of HCC increased 11% per calendar year (95% CI, 4%, 19%) and decreased 4% for other liver events (95% CI, 2%, 7%), but only the latter remained statistically significant after adjustment for potential confounders. Older age, cirrhosis, and low current CD4 cell count were associated with a higher incidence of both HCC and other liver events.CONCLUSIONS: In HIV/HCV-coinfected individuals, the crude incidence of HCC increased from 2001 to 2014, while other liver events declined. Individuals with cirrhosis or low current CD4 cell count are at highest risk of developing HCC or other liver events.

KW - Journal Article

U2 - 10.1093/cid/ciw380

DO - 10.1093/cid/ciw380

M3 - Journal article

C2 - 27307505

SN - 1058-4838

VL - 63

SP - 821

EP - 829

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this